SCHEMBL8410207

SCHEMBL8410207

CC(COc1ccc(CC(=O)Nc2ccc(C(C)C)cc2)cc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ HPGD P15428 2/20 0.54
▸ NLRP3 Q96P20 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.51
▸ MAPT P10636 3/20 0.50
▸ LMNA P02545 1/20 0.49
▸ RET P07949 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ ADRB1 P08588 3/20 0.47
▸ ADRB3 P13945 3/20 0.47
▸ CACNA1H O95180 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CNR2 P34972 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8411677 0.90 ADRB1 (0.57) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL8695260 0.89 SMN1; SMN2 (0.56) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL8411536 0.89 RAB9A (0.61) RAB9ANPC1SMN1; SMN2HPGDNLRP3
SCHEMBL8412806 0.88 GAA (0.61) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL1304060 0.85 SMN1; SMN2 (0.55) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL8700685 0.85 EPHX2 (0.54) RAB9ANPC1SMN1; SMN2HPGDNLRP3
SCHEMBL8412730 0.84 SMN1; SMN2 (0.47) RAB9ANPC1SMN1; SMN2HPGDNLRP3
SCHEMBL8411344 0.83 RORC (0.48) RAB9ANPC1SMN1; SMN2HPGDNLRP3
SCHEMBL8409841 0.83 SMN1; SMN2 (0.48) RAB9ANPC1SMN1; SMN2HPGDNLRP3
SCHEMBL13797602 0.82 SMN1; SMN2 (0.72) RAB9ASMN1; SMN2HPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5927283-A TREATING DISEASES INVOLVING OXYGEN DEFICIENCY, IN WOUND HEALING, AND IN RESTORING OXYGEN AFFINITY OF STORED BLOOD. VIRGINIA COMMONWEALTH UNIVERSITY (US) 1999-07-27 — — US disclosed
US-5872282-A MAINTAIN OXYGEN AFFINITY IN BLOOD WHEN STORED VIRGINIA COMMONWEALTH UNIVERSITY (US) 1999-02-16 — — US disclosed
US-5731454-A Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood VIRGINIA COMMONWEALTH UNIVERSITY (US) 1998-03-24 — — US disclosed
US-5705521-A Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors THE CENTER FOR INNOVATIVE TECHNOLOGY (US) 1998-01-06 — — US disclosed
US-5677330-A THERAPY HYPOXIA, HYPOTHERMIA, ISCHEMIC, WOUNDS, ULCERS, TISSUE TRANSPLANTS, SESPIS THE CENTER FOR INNOVATIVE TECHNOLOGY (US) 1997-10-14 — — US disclosed
Send feedback